A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Iron Dextran
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Mibefradil.
Iron Dextran
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Mibefradil.
Iron Dextran
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Mibefradil.
Iron Dextran
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Mibefradil.
Iron Dextran
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Mibefradil.
Iron Dextran
Thiothixene
The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Mibefradil.
Iron Dextran
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Mibefradil.
Iron Dextran
Hydroxychloroquine
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Mibefradil.
Iron Dextran
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Mibefradil.
Iron Dextran
Arformoterol
The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Mibefradil.
Iron Dextran
Alimemazine
The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Mibefradil.
Iron Dextran
Desflurane
The risk or severity of QTc prolongation can be increased when Desflurane is combined with Mibefradil.
Iron Dextran
Cyclizine
The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Mibefradil.
Iron Dextran
Levocabastine
The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Mibefradil.
Iron Dextran
Mequitazine
The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Mibefradil.
Iron Dextran
Gatifloxacin
The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Mibefradil.
Iron Dextran
Salbutamol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Mibefradil.
Iron Dextran
Maprotiline
The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Mibefradil.
Iron Dextran
Ketotifen
The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Mibefradil.
Iron Dextran
Emedastine
The risk or severity of QTc prolongation can be increased when Emedastine is combined with Mibefradil.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3